|
US20070122904A1
(en)
*
|
2000-09-29 |
2007-05-31 |
Unisearch Limited |
Method and apparatus for culturing cells
|
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
|
US20050009168A1
(en)
*
|
2003-05-12 |
2005-01-13 |
Robbins Joan Marie |
Methods and apparatus for Adeno associated virus purification
|
|
DE602004030327D1
(en)
|
2003-05-21 |
2011-01-13 |
Genzyme Corp |
METHOD FOR PRODUCING PREPARATIONS OF RECOMBINANT AAV VIRIONS LARGELY FREE FROM EMPTY CAPSIDES
|
|
US20040248826A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Alberto Auricchio |
Treatment of cancer by in vivo gene-transfer induced TIMP-3 expression
|
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
|
HUE060433T2
(en)
*
|
2004-06-01 |
2023-03-28 |
Genzyme Corp |
Compositions and methods to prevent aav vector aggregation
|
|
US7670837B2
(en)
|
2004-12-23 |
2010-03-02 |
Medimmune, Llc |
Non-tumorigenic MDCK cell line for propagating viruses
|
|
KR100823157B1
(en)
*
|
2004-12-30 |
2008-04-21 |
재단법인 목암생명공학연구소 |
How to mass produce recombinant adeno-associated viruses
|
|
WO2007127264A2
(en)
|
2006-04-28 |
2007-11-08 |
The Trustees Of The University Of Pennsylvania |
Scalable production method for aav
|
|
SG174813A1
(en)
*
|
2006-09-15 |
2011-10-28 |
Medimmune Llc |
Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
|
|
EP2031048B2
(en)
|
2007-08-31 |
2019-05-01 |
The Procter and Gamble Company |
Liquid acidic hard surface cleaning composition
|
|
EP2039748A1
(en)
|
2007-09-17 |
2009-03-25 |
The Procter and Gamble Company |
Process of treating inclined hard surface
|
|
EP2039747A1
(en)
|
2007-09-17 |
2009-03-25 |
The Procter and Gamble Company |
Process for treating hard surface
|
|
CA2738022A1
(en)
|
2008-09-24 |
2010-04-01 |
Medimmune, Llc |
Methods for cultivating cells, propagating and purifying viruses
|
|
CN102459611B
(en)
|
2009-05-02 |
2016-11-09 |
建新公司 |
The gene therapy of nerve degenerative diseases
|
|
BR112012018899A2
(en)
|
2010-01-28 |
2015-09-15 |
Philadelphia Children Hospital |
"Method for purifying adeno-associated virus vector particles."
|
|
WO2011097447A2
(en)
*
|
2010-02-04 |
2011-08-11 |
Neurologix, Inc. |
Production of recombinant virus
|
|
EP2625263B1
(en)
|
2010-10-08 |
2020-03-11 |
Terumo BCT, Inc. |
Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
JP6007463B2
(en)
|
2011-04-18 |
2016-10-12 |
国立研究開発法人国立精神・神経医療研究センター |
Drug delivery particle and method for producing the same
|
|
EP2714713B1
(en)
*
|
2011-05-26 |
2018-05-09 |
Dr. Reddy's Laboratories Limited |
Purification of anti-cd20 antibodies
|
|
US9840694B2
(en)
*
|
2011-09-08 |
2017-12-12 |
Uniqure Ip B.V. |
Removal of contaminating viruses from AAV preparations
|
|
JP6534933B2
(en)
|
2013-01-08 |
2019-06-26 |
ジェンザイム・コーポレーション |
Use of iNOS inhibitors to increase virus yield in culture
|
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
AU2014253919B2
(en)
|
2013-04-17 |
2019-06-20 |
Genzyme Corporation |
Compositions and methods for treating and preventing macular degeneration
|
|
EP3020808B1
(en)
*
|
2013-07-11 |
2019-09-11 |
Takara Bio Inc. |
Method for manufacturing adeno-associated virus
|
|
US20170007719A1
(en)
|
2014-02-06 |
2017-01-12 |
Genzyme Corporation |
Compositions and methods for treating and preventing macular degeneration
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
EP3168298B1
(en)
|
2014-07-10 |
2019-04-17 |
Takara Bio Inc. |
Production method for non-enveloped virus particles
|
|
EP3198006B1
(en)
|
2014-09-26 |
2021-03-24 |
Terumo BCT, Inc. |
Scheduled feed
|
|
SG11201703148TA
(en)
|
2014-11-05 |
2017-05-30 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
RU2716422C2
(en)
|
2014-11-14 |
2020-03-11 |
Вояджер Терапьютикс, Инк. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
US10570395B2
(en)
|
2014-11-14 |
2020-02-25 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
EP3243904A4
(en)
|
2015-01-09 |
2018-06-27 |
Takara Bio Inc. |
Method for producing non-enveloped viral particles
|
|
US9862936B2
(en)
|
2015-01-13 |
2018-01-09 |
Alfa Wassermann, Inc. |
Methods of purifying adeno-associated virus (AAV) and/or recombinant adeno-associated virus (rAAV) and gradients and flow-through buffers therefore
|
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
NZ743041A
(en)
*
|
2015-12-01 |
2025-02-28 |
Spark Therapeutics Inc |
Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
|
|
EP3387138B1
(en)
|
2015-12-11 |
2022-01-26 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
|
EP3387118B1
(en)
|
2015-12-11 |
2022-04-06 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
|
EP4215605A1
(en)
|
2015-12-11 |
2023-07-26 |
The Trustees of The University of Pennsylvania |
Scalable purification method for aav8
|
|
US11208630B2
(en)
*
|
2015-12-24 |
2021-12-28 |
University Of Florida Research Foundation, Incorporated |
AAV production using suspension adapted cells
|
|
KR102405250B1
(en)
|
2016-03-31 |
2022-06-02 |
스파크 테라퓨틱스, 인코포레이티드 |
Column-Based Fully Scalable rAAV Manufacturing Process
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
IL262784B2
(en)
|
2016-05-18 |
2023-10-01 |
Voyager Therapeutics Inc |
modulatory polynucleotides
|
|
KR102427379B1
(en)
|
2016-05-18 |
2022-08-02 |
보이저 테라퓨틱스, 인크. |
Compositions and methods for treating Huntington's disease
|
|
JP7034949B2
(en)
|
2016-05-25 |
2022-03-14 |
テルモ ビーシーティー、インコーポレーテッド |
Cell proliferation
|
|
JP2019530737A
(en)
|
2016-08-23 |
2019-10-24 |
アコーオス インコーポレイテッド |
Compositions and methods for treating non-aged hearing loss in human subjects
|
|
CN110650673B
(en)
|
2016-08-30 |
2024-04-09 |
加利福尼亚大学董事会 |
Methods for biomedical targeting and delivery and devices and systems for practicing the methods
|
|
KR20190104194A
(en)
|
2017-01-07 |
2019-09-06 |
셀렉타 바이오사이언시즈, 인크. |
Patterned Administration of Immunosuppressants Coupled to Synthetic Nanocarriers
|
|
JP7393945B2
(en)
|
2017-03-31 |
2023-12-07 |
テルモ ビーシーティー、インコーポレーテッド |
cell proliferation
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
WO2018204786A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN119491003A
(en)
|
2017-05-05 |
2025-02-21 |
沃雅戈治疗公司 |
Compositions and methods for treating Huntington's disease
|
|
KR20250030036A
(en)
|
2017-06-07 |
2025-03-05 |
스파크 테라퓨틱스, 인코포레이티드 |
ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
|
|
JOP20190269A1
(en)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
SG11201913157RA
(en)
*
|
2017-06-30 |
2020-01-30 |
Spark Therapeutics Inc |
Aav vector column purification methods
|
|
EP3654860A1
(en)
|
2017-07-17 |
2020-05-27 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
AU2018311069A1
(en)
|
2017-08-03 |
2020-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
AU2018338728B2
(en)
|
2017-09-29 |
2025-01-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Rescue of central and peripheral neurological phenotype of Friedreich's Ataxia by intravenous delivery
|
|
JP7502991B2
(en)
|
2017-10-16 |
2024-06-19 |
ボイジャー セラピューティクス インコーポレイテッド |
Treatment of amyotrophic lateral sclerosis (ALS)
|
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
WO2019133677A1
(en)
*
|
2017-12-29 |
2019-07-04 |
Baxalta Incorporated |
Adeno-associated virus purification methods
|
|
EP3762500A1
(en)
|
2018-03-06 |
2021-01-13 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
MX2020012077A
(en)
|
2018-05-15 |
2021-03-09 |
Voyager Therapeutics Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE.
|
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
|
EP3793686A1
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
IL319002A
(en)
|
2018-06-14 |
2025-04-01 |
Regenxbio Inc |
Anion exchange chromatography for recombinant aav production
|
|
JP7565218B2
(en)
|
2018-07-02 |
2024-10-10 |
ボイジャー セラピューティクス インコーポレイテッド |
Treatment of amyotrophic lateral sclerosis and spinal cord related disorders
|
|
CA3107462A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
CN109182281B
(en)
*
|
2018-08-31 |
2022-08-02 |
首都医科大学 |
Method and kit for treating adeno-associated virus
|
|
AU2019346655B2
(en)
|
2018-09-28 |
2025-03-13 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
WO2020072849A1
(en)
|
2018-10-04 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
WO2020150556A1
(en)
|
2019-01-18 |
2020-07-23 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
CA3138525A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
|
EP3962536A1
(en)
|
2019-04-29 |
2022-03-09 |
Voyager Therapeutics, Inc. |
Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors
|
|
WO2020264411A1
(en)
*
|
2019-06-28 |
2020-12-30 |
Baxalta Incorporated |
Adeno-associated virus purification methods
|
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021041485A1
(en)
|
2019-08-26 |
2021-03-04 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021124152A1
(en)
|
2019-12-19 |
2021-06-24 |
Pfizer Inc. |
Compositions and methods for nucleic acid transfection using cationic polymers and stabilizers
|
|
BR112022016596A2
(en)
|
2020-02-21 |
2022-11-16 |
Akouos Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN INDIVIDUAL
|
|
EP3919613B1
(en)
|
2020-06-05 |
2024-08-07 |
Sartorius BIA Separations d.o.o. |
Enhanced purification of adeno-associated virus to more effectively remove contaminating dna
|
|
US20230295656A1
(en)
|
2020-08-06 |
2023-09-21 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2022043926A1
(en)
*
|
2020-08-31 |
2022-03-03 |
Intas Pharmaceuticals Ltd. |
Process for preparation of recombinant adeno-associated virus particle
|
|
US20230366794A1
(en)
*
|
2020-09-23 |
2023-11-16 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
IL302046A
(en)
|
2020-10-15 |
2023-06-01 |
Hoffmann La Roche |
Nucleic acid structures for va RNA transcription
|
|
MX2023004178A
(en)
|
2020-10-15 |
2023-05-03 |
Hoffmann La Roche |
Nucleic acid constructs for simultaneous gene activation.
|
|
JP7683230B2
(en)
*
|
2021-01-27 |
2025-05-27 |
東ソー株式会社 |
Methods for purifying adeno-associated viruses
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4508241A1
(en)
|
2022-04-13 |
2025-02-19 |
F. Hoffmann-La Roche AG |
Method for determining aav genomes
|
|
GB202205514D0
(en)
*
|
2022-04-13 |
2022-05-25 |
Freeline Therapeutics Ltd |
Mechanical lysis
|
|
WO2023227438A1
(en)
|
2022-05-23 |
2023-11-30 |
F. Hoffmann-La Roche Ag |
Raman-based method for the differentiation of aav particle serotype and aav particle loading status
|
|
AU2023278422A1
(en)
|
2022-06-03 |
2024-11-14 |
F. Hoffmann-La Roche Ag |
Method for producing recombinant aav particles
|
|
AU2023305838A1
(en)
|
2022-07-14 |
2024-11-28 |
F. Hoffmann-La Roche Ag |
Method for producing recombinant aav particles
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
IL318766A
(en)
|
2022-09-12 |
2025-04-01 |
Hoffmann La Roche |
Method for separating full and empty aav particles
|
|
WO2024165456A1
(en)
|
2023-02-07 |
2024-08-15 |
F. Hoffmann-La Roche Ag |
Method for the detection of anti-aav particle antibodies
|
|
WO2024194280A1
(en)
|
2023-03-21 |
2024-09-26 |
F. Hoffmann-La Roche Ag |
Method for the production of recombinant aav particle preparations
|
|
WO2024206396A1
(en)
*
|
2023-03-28 |
2024-10-03 |
Biogen Ma Inc. |
Methods of recombinant adeno-associated virus (raav) production
|
|
WO2024211349A1
(en)
|
2023-04-03 |
2024-10-10 |
Genzyme Corporation |
Devices for cell lysis and methods of use thereof
|
|
WO2024233791A1
(en)
|
2023-05-11 |
2024-11-14 |
Seelos Therapeutics, Inc. |
Methods of treating neurodegenerative disorders
|